{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T07:19:40Z","timestamp":1787642380850,"version":"build-2736575974"},"reference-count":26,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.3892\/br.2016.711","type":"journal-article","created":{"date-parts":[[2016,6,30]],"date-time":"2016-06-30T11:46:00Z","timestamp":1467287160000},"page":"237-242","source":"Crossref","is-referenced-by-count":10,"title":["Single dose of rituximab in children with steroid-dependent minimal change nephrotic syndrome"],"prefix":"10.3892","volume":"5","author":[{"given":"Xiao-Ling","family":"Niu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui-Mei","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Yu","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Hua","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Yan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2016,6,30]]},"reference":[{"key":"key20180107141430_b1-br-0-0-711","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1007\/s004670100021","article-title":"Time trends and ethnic patterns of childhood nephrotic syndrome in Yorkshire, UK","volume":"16","author":"McKinney","year":"2001","journal-title":"Pediatr Nephrol"},{"key":"key20180107141430_b2-br-0-0-711","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1681\/ASN.V85769","article-title":"Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children","volume":"8","author":"Tarshish","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"key20180107141430_b3-br-0-0-711","first-page":"CD002290","article-title":"Non-corticosteroid treatment for nephrotic syndrome in children","volume":"1","author":"Hodson","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"key20180107141430_b4-br-0-0-711","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1136\/ard.2006.057885","article-title":"Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system","volume":"66","author":"Tokunaga","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"key20180107141430_b5-br-0-0-711","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1442-200X.2011.03432.x","article-title":"Rituximab for childhood refractory nephrotic syndrome","volume":"53","author":"Iijima","year":"2011","journal-title":"Pediatr Int"},{"key":"key20180107141430_b6-br-0-0-711","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/ki.2013.211","article-title":"Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome","volume":"84","author":"Ravani","year":"2013","journal-title":"Kidney Int"},{"key":"key20180107141430_b7-br-0-0-711","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s00467-009-1191-0","article-title":"Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children","volume":"24","author":"Kamei","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"key20180107141430_b8-br-0-0-711","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.2215\/CJN.03470410","article-title":"Efficacy and safety of treatment with rituximab for difficult steroid-resistant and -dependent nephrotic syndrome: Multicentric report","volume":"5","author":"Gulati","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"key20180107141430_b9-br-0-0-711","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/S0140-6736(14)60541-9","article-title":"Rituximab for Childhood-onset Refractory Nephrotic Syndrome (RCRNS) Study Group: Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial","volume":"384","author":"Iijima","year":"2014","journal-title":"Lancet"},{"key":"key20180107141430_b10-br-0-0-711","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s00467-009-1377-5","article-title":"Single infusion of rituximab for persistent steroid-dependent minimal-change nephrotic syndrome after long-term cyclosporine","volume":"25","author":"Fujinaga","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"key20180107141430_b11-br-0-0-711","first-page":"139","article-title":"Kidney Disease Improving Global Outcomes: KDIGO Clinical Practice Guideline for Glomerulonephritis","volume":"2","year":"2012","journal-title":"Kidney Int Suppl"},{"key":"key20180107141430_b12-br-0-0-711","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/S0022-3476(88)80570-5","article-title":"Predicting the response to cytotoxic therapy for childhood nephrotic syndrome: superiority of response to corticosteroid therapy over histopathologic patterns","volume":"113","author":"Schulman","year":"1988","journal-title":"J Pediatr"},{"key":"key20180107141430_b13-br-0-0-711","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00467-009-1376-6","article-title":"Rituximab in refractory nephrotic syndrome","volume":"25","author":"Prytu\u0142a","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"key20180107141430_b14-br-0-0-711","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s12519-014-0453-5","article-title":"Efficacy of rituximab therapy in children with refractory nephrotic syndrome: a prospective observational study in Shanghai","volume":"10","author":"Sun","year":"2014","journal-title":"World J Pediatr"},{"key":"key20180107141430_b15-br-0-0-711","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00467-012-2319-1","article-title":"Survey of rituximab treatment for childhood-onset refractory nephrotic syndrome","volume":"28","author":"Ito","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"key20180107141430_b16-br-0-0-711","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00467-012-2406-3","article-title":"Long-term outcome of children treated with rituximab for idiopathic nephrotic syndrome","volume":"28","author":"Tellier","year":"2013","journal-title":"Pediatr Nephrol"},{"key":"key20180107141430_b17-br-0-0-711","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1093\/ndt\/gfr405","article-title":"Rituximab in steroid-dependent idiopathic nephrotic syndrome in childhood - follow-up after CD19 recovery","volume":"27","author":"Sellier-Leclerc","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"key20180107141430_b18-br-0-0-711","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1093\/ndt\/gfr548","article-title":"Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndrome","volume":"27","author":"Kemper","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"key20180107141430_b19-br-0-0-711","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.2215\/CJN.09421010","article-title":"Short-term effects of rituximab in children with steroid- and calcineurin-dependent nephrotic syndrome: a randomized controlled trial","volume":"6","author":"Ravani","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"key20180107141430_b20-br-0-0-711","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00467-010-1465-6","article-title":"Rituximab efficiency in children with steroid-dependent nephrotic syndrome","volume":"25","author":"Sellier-Leclerc","year":"2010","journal-title":"Pediatr Nephrol"},{"key":"key20180107141430_b21-br-0-0-711","doi-asserted-by":"crossref","first-page":"973","DOI":"10.4103\/1319-2442.100878","article-title":"Rituximab in treatment of idiopathic glomerulopathy","volume":"23","author":"El-Reshaid","year":"2012","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"key20180107141430_b22-br-0-0-711","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1023\/B:JOCI.0000018063.55963.0c","article-title":"Online registry of genetic and clinical immunodeficiency diagnostic laboratories, IDdiagnostics","volume":"24","author":"Samarghitean","year":"2004","journal-title":"J Clin Immunol"},{"key":"key20180107141430_b23-br-0-0-711","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2215\/CJN.05691108","article-title":"Long-term outcome of biopsy-proven, frequently relapsing minimal-change nephrotic syndrome in children","volume":"4","author":"Kyrieleis","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"key20180107141430_b24-br-0-0-711","doi-asserted-by":"crossref","first-page":"242","DOI":"10.5414\/CNP60242","article-title":"Combined T- and B-cell activation in childhood steroid-sensitive nephrotic syndrome","volume":"60","author":"Kemper","year":"2003","journal-title":"Clin Nephrol"},{"key":"key20180107141430_b25-br-0-0-711","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s004670050592","article-title":"Up-regulation of interleukin-4 and CD23\/FcepsilonRII in minimal change nephrotic syndrome","volume":"13","author":"Cho","year":"1999","journal-title":"Pediatr Nephrol"},{"key":"key20180107141430_b26-br-0-0-711","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/eji.1830250604","article-title":"Involvement of interleukin (IL)-13, but not IL-4, in spontaneous IgE and IgG4 production in nephrotic syndrome","volume":"25","author":"Kimata","year":"1995","journal-title":"Eur J Immunol"}],"container-title":["Biomedical Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/br.2016.711\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T13:08:40Z","timestamp":1656767320000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/br.2016.711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,30]]},"references-count":26,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,6,30]]},"published-print":{"date-parts":[[2016,8]]}},"alternative-id":["10.3892\/br.2016.711"],"URL":"https:\/\/doi.org\/10.3892\/br.2016.711","relation":{},"ISSN":["2049-9434","2049-9442"],"issn-type":[{"value":"2049-9434","type":"print"},{"value":"2049-9442","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,30]]}}}